Granulocyta colonia stimuláló faktor terápia mellett kialakuló Sweet-szindróma.

Translated title of the contribution: Sweet syndrome following therapeutic use of granulocyte colony stimulating factor

K. Veres, A. Haraszti, Z. Nemes, M. Zeher

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Sweet's syndrome is an acute febrile neutrophilic dermatosis. Classical form occurs after infection of the gastrointestinal or respiratory tract. This syndrome is often associated with myeloproliferative disorders and solid tumors. Some cases are reported in the literature in which usage of granulocyte colony-stimulating factor induced the symptoms of Sweet's syndrome. We report the case of an 53-year-old woman with hyperthyreosis. She wasn't euthyreoid in spite of medicaments since 1994, so her doctors planned operation. In the preoperative period her peripheral blood revealed agranulcytosis and she has got fever. 2 days after administration of granulocyte colony-stimulating factor erythematous plaques appeared on her face, neck and extremities. Biopsy from these plaques showed dermal neutrophilia, so a diagnosis of neutrophilic dermatosis was made. After the administration of corticosteroids, immunglobulin and antibiotics the skin lesions were resolved. She was examined because of suspicion of autoimmune diseases but we couldn't find any of them. Retrospectively, appearance of Sweet's syndrome was associated with granulocyte colony-stimulating factor. The case of this woman is important because usage of colony-stimulating factors is widespread and the Sweet's syndrome could be occurs as side effect of these drugs.

Translated title of the contributionSweet syndrome following therapeutic use of granulocyte colony stimulating factor
Original languageHungarian
Pages (from-to)1059-1061
Number of pages3
JournalOrvosi hetilap
Volume140
Issue number19
Publication statusPublished - May 9 1999

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Sweet syndrome following therapeutic use of granulocyte colony stimulating factor'. Together they form a unique fingerprint.

  • Cite this